In vitro susceptibility testing of Candida and Aspergillus spp. to voriconazole and other antifungal agents using Etest®: results of a French multicentre study

Mallié, M.; Bastide, J.-M.; Blancard, A.; Bonnin, Alain; Bretagne, Stéphane; Cambon, M.; Chandenier, J.; Chauveau, V.; Couprie, B.; Datry, A.; Feuilhade, M.; Grillot, R.; Guiguen, Claude; Lavarde, V.; Letscher, V.; Linas, M. D.; Michel, Albin; Morin, O.; Paugam, A.; Piens, Marie‐Antoinette; Rabérin, H.; Tissot, E; Toubas, D.; Wade, Amath

doi:10.1016/j.ijantimicag.2004.11.010

Cited by 60 publications

(28 citation statements)

References 40 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Among other azoles, in vitro resistance to itraconazole has been noted, occurring at rates of from 1.5% of C. parapsilosis isolates (10) to 4% (202), and voriconazole has lower MIC 50 (Յ0.03 g/ml) and MIC 90 (Յ0.03 to 0.12 g/ml) values than amphotericin B and older azoles against C. parapsilosis (88,166,168,177,202,218). In vitro resistance to voriconazole is rare, with early reports showing 100% susceptibility (214).…”

Section: Antimicrobial Susceptibilitymentioning

confidence: 99%

Candida parapsilosis, an Emerging Fungal Pathogen

2008

View full text Add to dashboard Cite

SUMMARY Candida parapsilosis is an emerging major human pathogen that has dramatically increased in significance and prevalence over the past 2 decades, such that C. parapsilosis is now one of the leading causes of invasive candidal disease. Individuals at the highest risk for severe infection include neonates and patients in intensive care units. C. parapsilosis infections are especially associated with hyperalimentation solutions, prosthetic devices, and indwelling catheters, as well as the nosocomial spread of disease through the hands of health care workers. Factors involved in disease pathogenesis include the secretion of hydrolytic enzymes, adhesion to prosthetics, and biofilm formation. New molecular genetic tools are providing additional and much-needed information regarding C. parapsilosis virulence. The emerging information will provide a deeper understanding of C. parapsilosis pathogenesis and facilitate the development of new therapeutic approaches for treating C. parapsilosis infections.

show abstract

Section: Antimicrobial Susceptibilitymentioning

confidence: 99%

Candida parapsilosis, an Emerging Fungal Pathogen

2008

View full text Add to dashboard Cite

show abstract

“…The screening for the palladium chloride salts and new complexes were performed at the fixed amount of 0.1 mg. Based on the obtained values of the relative zone inhibition, 24,25) 1 and 2 complexes were found to be very effective against Gram-positive Staphylococcus aureus and Gram-negative Escherichia coli bacteria, Table 4.…”

Section: Resultsmentioning

confidence: 99%

Antibacterial Activity of Pd(II) Complexes with Salicylaldehyde-Amino Acids Schiff Bases Ligands

Rîmbu¹,

Danac

Pui

2014

Chem. Pharm. Bull.

View full text Add to dashboard Cite

Key words salicylaldehyde-amino acid Schiff base; Pd(II) complex; antibacterial activity As bacterial drug resistance to currently administered treatments is increasing, the need for the development of new therapeutic strategies against bacterial infection becomes more stringent. Therefore, there is an urgent demand for the development of new antimicrobial agents with improved properties such as enhanced activity, reduced toxicity and shortened duration of therapy.

show abstract

“…The results were expressed in terms of active and inactive. Further minimum inhibitory concentrations of all active compounds were determined [25][26][27] .…”

Section: Antibacterial Activitymentioning

confidence: 99%